
Stent designers have spent decades pursuing this goal, with little success. But drug and medical-devices company Abbott Laboratories --the leader in old-style, bare-metal stents, with $24 billion in revenues--is finally showing progress. Abbott's new stent, called Absorb, is made of polylactic acid and coated with a drug called Everolimus; the water in the artery wall eventually breaks down the polylactic acid into lactic acid, a naturally produced substance. That lactic acid is then absorbed into the body as carbon dioxide and water, leaving nothing behind."
A Abbott desenvolveu um novo endoprótese expansível reabsorvíeis pelo corpo que pode revolucionar o mundo da cirurgia cardiovascular. Um negócio de $ 5 biliões.
Sem comentários:
Enviar um comentário